We are live on ! Find out more
AGN

Allergan plc
AGN

Delisted

AGN was delisted on the 8th of May, 2020.

1,056 hedge funds and large institutions have $96.1B invested in Allergan plc in 2015 Q3 according to their latest regulatory filings, with 121 funds opening new positions, 402 increasing their positions, 407 reducing their positions, and 93 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% more first-time investments, than exits

New positions opened: 121 | Existing positions closed: 93

15% more call options, than puts

Call options by funds: $1.73B | Put options by funds: $1.51B

2% more funds holding

Funds holding: 1,0351,056 (+21)

1% less repeat investments, than reductions

Existing positions increased: 402 | Existing positions reduced: 407

7% less capital invested

Capital invested by funds: $103B → $96.1B (-$7.12B)

11% less funds holding in top 10

Funds holding in top 10: 176157 (-19)

Holders
1,056
Holders Change
+21
Holders Change %
+2.03%
% of All Funds
29.47%
Holding in Top 10
157
Holding in Top 10 Change
-19
Holding in Top 10 Change %
-10.8%
% of All Funds
4.38%
New
121
Increased
402
Reduced
407
Closed
93
Calls
$1.73B
Puts
$1.51B
Net Calls
+$223M
Net Calls Change
+$273M
Name Holding Trade Value Shares
Change
Change in
Stake
HNB
426
Huntington National Bank
Ohio
$8.71M +$645K +2,100 +7%
TCM
427
TimesSquare Capital Management
New York
$8.68M -$696K -2,265 -7%
GI
428
GAMCO Investors
Connecticut
$8.66M -$1.67M -5,424 -15%
HighTower Advisors
429
HighTower Advisors
Illinois
$8.62M +$2.69M +8,751 +38%
LBC
430
Lowe Brockenbrough & Co
Virginia
$8.47M -$36.2K -118 -0.4%
AC
431
Allstate Corporation
Illinois
$8.43M -$12M -39,114 -56%
GMI
432
Greystone Managed Investments
Saskatchewan, Canada
$8.41M -$10.8M -35,299 -53%
EIM
433
Essex Investment Management
Massachusetts
$8.4M -$406K -1,321 -4%
PP
434
Palladium Partners
Virginia
$8.32M +$1.19M +3,886 +15%
FPA
435
First Pacific Advisors
California
$8.31M +$9.39M +30,580 New
RS
436
Robeco Schweiz
Switzerland
$8.29M
SIM
437
Sentry Investment Management
Wisconsin
$8.15M +$203K +662 +2%
AP
438
Archon Partners
New Jersey
$8.06M
Arrowstreet Capital
439
Arrowstreet Capital
Massachusetts
$7.94M -$130M -422,787 -94%
Northwestern Mutual Wealth Management
440
Northwestern Mutual Wealth Management
Wisconsin
$7.87M +$4.11M +13,387 +86%
LSERS
441
Louisiana State Employees Retirement System
Louisiana
$7.83M +$61.4K +200 +0.7%
Commonwealth Equity Services
442
Commonwealth Equity Services
Massachusetts
$7.8M -$683K -2,225 -7%
CPSAC
443
Chas P. Smith & Associates (CPS)
Florida
$7.8M +$664K +2,162 +8%
KAS
444
Kemnay Advisory Services
New York
$7.75M +$1.33M +4,319 +18%
SRCM
445
Swift Run Capital Management
Virginia
$7.69M +$33.8K +110 +0.4%
WCMN
446
Westchester Capital Management (Nebraska)
Nebraska
$7.63M -$70.7K -230 -0.8%
PCM
447
Pentwater Capital Management
Florida
$7.62M +$5.34M +17,400 +163%
VOAM
448
Vertex One Asset Management
British Columbia, Canada
$7.47M -$15.4M -50,000 -65%
HCMT
449
Highland Capital Management (Texas)
Texas
$7.43M -$41.4M -134,888 -83%
KRS
450
Kentucky Retirement Systems
Kentucky
$7.34M +$163K +530 +2%

AGN Hedge Fund Activity: Q3 2015 in Review

1,056 of the 3,583 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q3 2015, worth a combined $96.1B — down 6.9% from $103B a quarter earlier.

Buyers outnumbered sellers: 121 funds opened new AGN positions and 93 closed out — a net gain of 28 holders — while 402 added to existing stakes and 407 trimmed.

The largest buyer was Norges Bank, opening a new position worth an estimated $1.01B. The largest seller was Fidelity Investments, cutting an estimated $1.45B.

  • 1,056 institutional investors held Allergan plc (AGN) as of Q3 2015, up from 1,035 in Q2 2015.
  • Funds reported $96.1B of Allergan plc stock for Q3 2015, down 6.9% quarter-over-quarter.
  • 121 funds opened new Allergan plc positions in Q3 2015 and 93 closed out, a net change of +28 holders.
  • The largest Allergan plc buyer in Q3 2015 was Norges Bank, an estimated $1.01B added.
  • The largest Allergan plc seller in Q3 2015 was Fidelity Investments, an estimated $1.45B sold.

Based on aggregated 13F filings for Q3 2015.